Deep 6 AI and Magnolia Market Access Partner to Accelerate Real-World Evidence (RWE) Projects for Life Sciences Companies and Healthcare Organizations
PASADENA, Calif., May 2, 2024 /PRNewswire/ -- Deep 6 AI, the leader in AI-powered patient recruitment and real-world data (RWD), together with Magnolia Market Access, a provider of tailored RWD insights and strategies for market access, health economics and outcomes research (HEOR), and healthcare policy, today announced a partnership to accelerate stakeholder decision-making across the pharmaceutical, biologic, and medical device product lifecycle. The combined RWE generation solution uses AI to develop fit-for-purpose, analysis-ready clinical data sets from electronic medical record (EMR) data months faster than traditional approaches.
- Typically, it can take life sciences companies a year or more to contract with healthcare organizations to gain access to EMR data.
- "The speed and precision with which we generate clinical insights is paramount to our life sciences customers' success," said Amanda Forys, Managing Partner at Magnolia Market Access.
- Life sciences companies can meet Deep 6 AI and Magnolia Market Access at ISPOR 2024 , May 5 to 8 in Atlanta, Georgia.
- Contact Deep 6 AI or Magnolia Market Access to schedule a meeting.